Pharmacology of pressor agents on the systemic circulation.
D000200:Action Potentials / Q000187:drug effects; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008616:Mephentermine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D010909:Pituitary Hormones, Posterior / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D012769:Shock / Q000188:drug therapy*; D012770:Shock, Cardiogenic; D012771:Shock, Hemorrhagic / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D010909:Pituitary Hormones, Posterior; D011941:Receptors, Adrenergic; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D010656:Phenylephrine; D008680:Metaraminol; D008729:Methoxamine; D007545:Isoproterenol; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine